Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The observations are procedural in nature and will be responded to within the stipulated time
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
The Product is expected to be the first generic approval on the market
A game changing solution for the pharmaceutical industry
Highly effective preservation solutions ensuring the safety and protection of personal care products
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
The company plans to add 1700 beds by FY27 through the organic route
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
